Literature DB >> 9142145

Late development of bile duct cancer after sphincteroplasty: a ten- to twenty-two-year follow-up study.

K Hakamada1, M Sasaki, M Endoh, T Itoh, T Morita, M Konn.   

Abstract

BACKGROUND: Transduodenal sphincteroplasty is designed to destroy the sphincteric muscle fibers, producing a terminal choledochoduodenostomy. In the absence of Oddi's sphincter, intestinal contents with both activated pancreatic juice and bacterial flora are refluxed into the bile duct and remain there for a prolonged time. The long-term effect of producing the reflux has not been evaluated to date.
METHODS: One hundred nineteen consecutive patients undergoing transduodenal sphincteroplasty between February 1973 and July 1984 were included in this study. Postoperative clinical courses of 108 patients could be evaluated by means of a retrospective review of the hospital records. Median follow-up was 18 years.
RESULTS: Eight cases (7.4%) of primary bile duct cancer were found among the 108 cases at intervals of 1 to 20 years after sphincteroplasty. Two patients had concurrent hepatolithiasis. The patency of sphincteroplasty was confirmed in all cases, and the bile was infected in seven cases. Pathologic specimens obtained demonstrated cholangiocarcinomas and various degrees of atypical hyperplastic lesions under the background of chronic cholangitis.
CONCLUSIONS: Chronic cholangitis can be an important causative factor in late development of bile duct cancer after sphincteroplasty. Any patients treated with choledochoduodenostomy should be closely monitored for late cholangiocarcinoma.

Entities:  

Mesh:

Year:  1997        PMID: 9142145     DOI: 10.1016/s0039-6060(97)90101-x

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  25 in total

Review 1.  Photodynamic therapy in the biliary tract.

Authors:  M Ortner
Journal:  Curr Gastroenterol Rep       Date:  2001-04

Review 2.  Cholangiocarcinoma arising after biliary-enteric drainage procedures for benign disease.

Authors:  V Bettschart; R A E Clayton; R W Parks; O J Garden; C O C Bellamy
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

3.  A stone extraction facilitation device to achieve an improved technique for performing LCBDE.

Authors:  D E Wenner; P Whitwam; J Rosser; S Hashmi; D E Wenner
Journal:  Surg Endosc       Date:  2004-11-11       Impact factor: 4.584

4.  Dilation-assisted stone extraction: an alternative method for removal of common bile duct stones.

Authors:  Guodong Li; Qiuping Pang; Xiujuan Zhang; Haiyan Dong; Rong Guo; Hailan Zhai; Yanchun Dong; Xinyong Jia
Journal:  Dig Dis Sci       Date:  2013-11-20       Impact factor: 3.199

Review 5.  Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009.

Authors:  Murad Aljiffry; Mark J Walsh; Michele Molinari
Journal:  World J Gastroenterol       Date:  2009-09-14       Impact factor: 5.742

Review 6.  Cholangiocarcinoma--controversies and challenges.

Authors:  Tushar Patel
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-04       Impact factor: 46.802

7.  Effects of endoscopic sphincterotomy on biliary epithelium: a case-control study.

Authors:  John Kalaitzis; Antonios Vezakis; George Fragulidis; Irene Anagnostopoulou; Spyros Rizos; Efstathios Papalambros; Andreas Polydorou
Journal:  World J Gastroenterol       Date:  2012-02-28       Impact factor: 5.742

8.  Can endoscopic papillary balloon dilation really preserve sphincter of Oddi function?

Authors:  I Yasuda; E Tomita; M Enya; T Kato; H Moriwaki
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

Review 9.  Endoscopic retrograde cholangiopancreatography in children: Retrospective series with a long-term follow-up and literature review.

Authors:  Yavor Asenov; Melih Akın; Serdar Cantez; Feryal Gün Soysal; Yaman Tekant
Journal:  Turk J Gastroenterol       Date:  2019-02       Impact factor: 1.852

10.  Is Oddi sphincterotomy an indication for hepatolithiasis?

Authors:  Xiaofeng Ling; Zhi Xu; Lixin Wang; Chunsheng Hou; Dianrong Xiu; Tonglin Zhang; Xiaosi Zhou
Journal:  Surg Endosc       Date:  2009-01-28       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.